Actavis UK raised drug prices 12,000 percent, watchdog finds

(Reuters) - Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12,000 percent, Britain's competition watchdog said in a provisional ruling on Friday.